Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
Rambaldi A, Iurlo A, Vannucchi AM, Noble R, von Bubnoff N, Guarini A, Martino B, Pezzutto A, Carli G, De Muro M, Luciani S, McMullin MF, Cambier N, Marolleau JP, Mesa RA, Tibes R, Pancrazzi A, Gesullo F, Bettica P, Manzoni S, Di Tollo S. Rambaldi A, et al. Among authors: luciani s. Leukemia. 2020 Aug;34(8):2234-2237. doi: 10.1038/s41375-020-0735-y. Epub 2020 Feb 11. Leukemia. 2020. PMID: 32047238 Free PMC article. Clinical Trial. No abstract available.
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
Rambaldi A, Iurlo A, Vannucchi AM, Martino B, Guarini A, Ruggeri M, von Bubnoff N, De Muro M, McMullin MF, Luciani S, Martinelli V, Nogai A, Rosti V, Ricco A, Bettica P, Manzoni S, Di Tollo S. Rambaldi A, et al. Among authors: luciani s. Blood Cancer J. 2021 Mar 6;11(3):53. doi: 10.1038/s41408-021-00445-z. Blood Cancer J. 2021. PMID: 33677466 Free PMC article. Clinical Trial.
Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective study.
Ricciuti G, Finolezzi E, Luciani S, Ranucci E, Federico M, Di Nicola M, Zecca IAL, Angrilli F. Ricciuti G, et al. Among authors: luciani s. Hematol Oncol. 2018 Feb;36(1):44-48. doi: 10.1002/hon.2386. Epub 2017 Feb 3. Hematol Oncol. 2018. PMID: 28156055
Latin America and the Caribbean Code Against Cancer 1st Edition: 17 cancer prevention recommendations to the public and to policy-makers (World Code Against Cancer Framework).
Espina C, Feliu A, Maza M, Almonte M, Ferreccio C, Finck C, Herrero R, Dommarco JR, de Almeida LM, Arrossi S, García PJ, Garmendia ML, Mohar A, Murillo R, Santamaría J, Tortolero-Luna G, Cazap E, Gabriel OO, Paonessa D, Zoss JW, Luciani S, Carvalho A, Schüz J; Working Groups of Scientific Experts. Espina C, et al. Among authors: luciani s. Cancer Epidemiol. 2023 Oct;86 Suppl 1:102402. doi: 10.1016/j.canep.2023.102402. Epub 2023 Oct 16. Cancer Epidemiol. 2023. PMID: 37852725 Free article.
Collaboration for success: the Global Initiative for Childhood Cancer in Latin America.
Vásquez L, Fuentes-Alabi S, Benitez-Majano S, Ribeiro KB, Abraham M, Agulnik A, Baker JN, Blanco DB, Caniza MA, Cardenas-Aguirre A, Salaverria C, Sullivan CE, Damasco-Avila E, García-Quintero X, Loggetto P, McNeil MJ, Luna-Fineman S, Rossell N, Garcia de Lima RA, de Mendonca RH, Trigoso V, Segovia L, Vasquez R, Moreno F, Friedrich P, Luciani S, Lam C, Metzger ML, Rodríguez-Galindo C, Maza M. Vásquez L, et al. Among authors: luciani s. Rev Panam Salud Publica. 2023 Oct 4;47:e144. doi: 10.26633/RPSP.2023.144. eCollection 2023. Rev Panam Salud Publica. 2023. PMID: 37799823 Free PMC article.
206 results